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Endoscopic Balloon Dilation of Esophageal Strictures in 9 Horses
J.S.W. Prutton, S.L. Marks, and M. Aleman
Background: Medical treatment of esophageal strictures in horses is limited and the use of balloon dilatation is described
in few cases. Long-term follow up after balloon dilatation and the use of intralesional corticosteroids has not been evaluated.
Objectives: To describe the use of endoscopic guided, esophageal balloon dilatation in horses for cervical and thoracic
esophageal strictures and administration of intralesional corticosteroids at the time of dilatation.
Animals: Nine horses from the hospital population with benign esophageal strictures.
Methods: Retrospective study: Medical records were reviewed from horses presented to the William R. Pritchard, Veteri-
nary Medical Teaching Hospital at UC Davis from 2002 to 2013. Records were searched using the key words: equine, horse,
balloon dilatation, bougienage, and esophageal stricture.
Results: Nine horses with esophageal strictures were treated with esophageal balloon dilatation. Five horses survived (sur-
vival at writing ranged from 2 to 11 years after discharge) and all nonsurvivors were <1 year of age and presented with con-
current problems or developed complications including megaesophagus, unresolved esophageal obstruction requiring
esophagostomy, or severe aspiration pneumonia. Four horses were treated with intralesional corticosteroids with no adverse
effects noted in the survivors (n = 3). Four horses available for long-term follow up were alive at 2, 5, 6, and 11 years after
presentation and 3 of these horses were being fed a hay-based diet.
Conclusions: Resolution of esophageal strictures in the horse can be performed successfully, safely, and under standing
sedation using balloon dilatation. Intralesional corticosteroids might reduce the incidence of recurrent strictures.
Key words: Bougienage; Choke; Esophagus; Horse.
Esophageal strictures in horses can occur afteresophageal obstruction, nasogastric intubation,
external trauma, congenital defects, or as a complica-
tion of esophageal surgery.1–3 Esophageal impaction is
often cited as the cause of strictures in horses4 and the
esophageal damage is dependent on the duration and
the material present in the obstruction. Prolonged
esophageal impaction can cause pressure necrosis with
concurrent erosions or ulcerations of the esophageal
mucosa, and/or muscularis, leading to esophageal fibro-
sis.2 Esophageal strictures occur when fibrosis is associ-
ated with thickening of the esophageal wall. The
strictures can be classified into 3 types based on the
esophageal wall layers affected: type I lesions involve
the adventitia and tunica muscularis; type II lesions
involve only the mucosa and submucosa; and type III
lesions involve all 4 layers of the esophageal wall.2,5
Surgical treatment of esophageal strictures in horses
is limited because of the high rate of complications.1,2,6
Balloon dilatation and bougienage offer alternative
treatments for strictures and have shown good results in
small animals7–10 as well as in a small number of
horses.11–13 Complications of esophageal dilatation
include bleeding, mucosal tearing, perforation, divertic-
ulum formation, infection, aspiration pneumonia, and
stricture recurrence.14 Recurrence has been attributed to
ongoing inflammatory processes and collagen forma-
tion.14 The use of intralesional corticosteroids has been
advocated as a treatment for recurrent strictures in
humans to minimize stricture reformation;15 however,
corticosteroid administration carries a possible risk of
laminitis in horses.16
The aim of this study was to describe the use of
endoscopic balloon dilatation for cervical and thoracic
esophageal strictures and report long-term outcome in 9
horses. Furthermore, the use of intralesional corticoste-
roid administration at the time of dilatation was also
described.
Materials and Methods
Medical records from horses presented to The William R. Prit-
chard Veterinary Medical Teaching Hospital at UC Davis from
2002 to 2013 were retrospectively reviewed. Records were searched
for the key words: equine, horse, balloon dilatation, bougienage,
and esophageal stricture. Cases were eligible for inclusion in this
study if an esophageal stricture was confirmed during clinical
examination and it was treated with balloon dilatation with, or
without, intralesional corticosteroids. Descriptive data are pre-
sented as mean, median, and range unless otherwise stipulated.
Nine cases were retrieved and the following information (when
recorded) was obtained from each medical record: signalment,
clinical signs and their duration, diet before presentation, dental
history, suspected cause of stricture, physical examination and
clinical laboratory findings, diagnostic modalities used, number,
size and location of strictures, mucosal damage before and after
dilatation, balloon size utilized, use of intralesional steroid ther-
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apy, postdilatation treatment including feeding, clinical response,
and follow up. The diameter of the stricture (when noted) was esti-
mated based on the size of the endoscope used. The location, and
in some cases the length, of the stricture was measured from the
nares to the orad border of the stricture.
Results
Case Signalment and Clinical Findings
The 9 cases comprised 1 gelding, 3 stallions, 2 colts,
and 3 mares. Breeds included: American Miniature Horse
(n = 2), Quarter Horse (n = 2), Thoroughbred (n = 1),
Pony of the Americas (n = 1), Shetland Pony (n = 1),
Gypsy Cobb (n = 1), and Friesian (n = 1). Ages ranged
from 2 days to 28 years (mean 6.6 years, median 1 year).
Two cases had intermittent esophageal obstruction of
1 week and 5 months duration, respectively. Both cases
had spontaneous resolution of their episodes until
referred for persistent obstruction of approximately
24 hours. The acute duration of esophageal obstruction
was known in 6/7 of the remaining horses and ranged
from 1 hours to 3 days (mean 33.6 hours, median
24 hours). The total number of esophageal obstruction
episodes ranged from a single episode in 5 horses, 1–5
episodes in 1 horse, 5–10 episodes in 1 horse and >20
episodes in 2 horses.
On presentation all horses had nasal discharge of
green, mucopurulent material, or feed material. Abnor-
mal physical examination findings included pyrexia in
2/9 horses of 102.8 and 101.8°F (mean 100.5°F, median
100.1°F), tachycardia in 8/9 horses (mean 56 bpm, med-
ian 52 bpm), and tachypnea in 5/9 horses (mean
30 bpm, median 24 bpm). Eight horses had abnormal
respiratory sounds on auscultation including crackles
and areas of undetectable breath sounds. Dental records
were recorded for only 2 horses (both 24 years); one had
severe wave mouth and the other was reported to have a
normal dental evaluation 4 years previously. Other
physical examination findings were within normal limits.
The diet before presentation varied dramatically and
included grass and alfalfa hay (n = 4), milk with access to
mare’s feed (n = 4), and a complete pelleted feed (n = 1).
Laboratory Findings
Complete blood cell counts and serum biochemistry
panels were performed on all cases upon admission.
The hematocrit was within normal limits for all horses
with the exception of 2 horses that had microcytic, nor-
mochromic anemias of 25% (MCV 26.6 fL and MCHC
40.7 g/dL) and 27% (MCV 34 fL and MCHC 39.2
g/dL), respectively (MCV reference range 37–53 fL;
MCHC reference range 36–41 g/dL). A neutrophilia
was seen in 3 horses (11,934–18,181/lL; reference range
5,000–11,600/lL) all of which did not survive, while
band neutrophils (122–622/lL; reference range: rare)
were detected in 4 horses of which 1 did not survive.
Slight toxicity of both the bands and the mature neu-
trophils was noted in the 3 surviving horses. Serum cre-
atinine concentration was increased in 1 horse (2.6 mg/
dL; reference range 0.9–2.0 mg/dL) and BUN concen-
tration was increased in 2 horses (64 and 95 mg/dL; ref-
erence range 25–53 mg/dL) with the latter of the 2
horses also having an elevated creatinine. The horse
with the elevated creatinine and BUN had shown clini-
cal signs of esophageal obstruction for 72 hours, while
the other horse had clinical signs for 24 hours. Hyper-
glycemia was documented in 3 horses (180–329 mg/dL;
reference range 54–108 mg/dL); creatine kinase activity
was increased in 4 horses (357–902 IU/L; reference
range 119–287 IU/L); and serum triglyceride concentra-
tion was elevated in 4 horses (45–239 mmol/L; reference
range 0–44 mmol/L). The hyperglycemia was monitored
in all horses and resolved after resolution of the esopha-
geal obstruction and fluid therapy.
Diagnostic Procedures
Diagnostics procedures that confirmed the presence
of a stricture included esophagoscopy (n = 9), esopha-
gram (Fig 1; n = 2), video fluoroscopy with barium
(n = 1), and computed tomography (n = 1). Pneumonia
was diagnosed via auscultation (n = 8), survey radio-
graphs of the thorax (n = 5), and ultrasonography of
the thorax (n = 2). Cervical survey radiographs (n = 2)
and cervical ultrasonography (n = 1) was also per-
formed to further characterize the esophageal stricture.
Esophageal strictures were most frequently associated
with an obstruction (n = 6). Other etiologies included
trauma (n = 1), intramural cyst (n = 1), and unknown
(n = 1). Abnormalities noted during sedated endoscopic
examination included decreased esophageal motility
associated with megaesophagus orad to the stricture
(n = 1), megaesophagus caudal to the stricture (n = 1),
and a dorsal pharyngeal recess rupture into the guttural
pouch attributable to attempted naso-gastric intubation
by the owner (n = 1).
Esophageal strictures were measured from the exter-
nal nares to the orad border of the stricture, and were
located at 35–70 cm (mean 46 cm, median 41 cm)
Fig 1. Esophagram of a 2-month filly with a thoracic esophageal
stricture (small arrow) and megaesophagus (large arrow) orad to
the stricture performed under standing sedation. Barium pooling
can be noted orad and caudal to the stricture site.
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within the cervical region in 8 horses, whereas one stric-
ture in 1 horse was located at 90 cm in the thoracic
region. Three horses had multiple strictures (exact num-
ber not recorded), whereas the remainder of the horses
had a single stricture as diagnosed by esophagoscopy.
Stricture lengths were recorded in 5 horses ranging from
1 to 10 cm (mean 4.4 cm, median 5 cm) and the length
was not recorded for the remaining 4 horses. Six horses
were noted to have circumferential mucosal sloughing
and ulceration at the site of the stricture when first
diagnosed and all 6 of these horses had presented with
esophageal obstruction.
Treatment and Outcome
Seven horses were administered isotonic fluids IV for
rehydration and maintenance of fluid requirements.
During balloon dilatation all horses were administered
nonsteroidal anti-inflammatories (flunixin megluminea)
at 1.1 mg/kg, IV, q 12 h (n = 9) and phenylbutazoneb
at 2.2 mg/kg, PO, q 12 h (n = 1) with 1 horse receiving
both drugs. Multimodal analgesia combined with NSA-
IDs was used in 6 horses and included 20 mL of 2%
lidocaine hydrochloridec (n = 1) via the endoscope at
the stricture site, butylscopolamined 0.1–0.3 mg/kg IV
once (n = 3), butylscopolamined and butorphanol tar-
tratee 0.04 mg/kg IV once (n = 1), or butylscopolamined
and morphinef 0.1 mg/kg IM once (n = 1).
All horses received antibiotics including aminoglyco-
sides (gentamicing 6.6 mg/kg IV q 24 h [n = 4] or ami-
kacinh 20 mg/kg IV q 24 h [n = 2]), penicillins
(procaine penicillin Gi 22,000 mg/kg IM q 12 h [n = 2]
or ampicillinj 20 mg/kg IV q 8 h [n = 1]), ceftiofur
sodiumk 2.2 mg/kg IV q 12 h (n = 5), metronidazolel
20 mg/kg PO q 8 h (n = 2), trimethoprim sulfonamidem
30 mg/kg PO q 12 h (n = 1), or doxycyclinen 10 mg/kg
PO q 12 h (n = 1).
Gastroprotectants were used in 6 horses including
omeprazoleo 4 mg/kg PO q 24 h (n = 1), sucralfatep
tablets reconstituted with water 20–40 mg/kg PO q 6–
8 h (n = 2), omeprazoleo and sucralfatep tablets (n = 2),
or omeprazoleo, sucralfatep tablets, and ranitidineq at
6.6 mg/kg PO q 8 h (n = 1).
Esophagoscopy of the entire esophagus was per-
formed during initial examination in all horses after res-
olution of esophageal obstructions when present. After
localization of the stricture (Fig 2), esophageal dilata-
tion was performed using a controlled radial expansion
wire-guided balloon catheter.r The balloon catheters
used ranged in diameter from 6 to 20 mm and were 3–
8 cm long. The diameter of the balloon dilator initially
selected was based on the measured diameter of the
stricture before dilatation. Specifically, the authors
selected a balloon dilator with a maximal diameter of
25–50% greater than the diameter of the stricture and
used varying filling pressures to incrementally reach the
desired stricture diameter, as set out by manufacturer’s
instructions. A second balloon dilator with a slightly
greater outer diameter than the first balloon was then
introduced into the stricture using the same guidelines
highlighted above. Each of the balloon dilators facili-
tated expansion of the esophageal stricture up to 3 mm
beyond the balloons smallest diameter. The outer diam-
eter of subsequent larger diameter balloon dilators over-
lapped with the outer diameter of previously used
balloon dilators allowing for a gradual and progressive
expansion of the stricture. For example, the smallest
balloon dilator used had a range of inflated outer diam-
eters of 6–8 mm, and subsequent balloon dilators had
inflated outer diameters of 8–10 mm, 10–12 mm, 12–
15 mm, 15–18 mm, and finally 18–20 mm. Accurate
insufflation and pressure maintenance of the balloon
with water was performed using a manometric pressure
Fig 2. Severe esophageal stricture in a 24-year-old miniature
horse gelding with a 0.8 cm diameter after esophageal impaction.
Fig 3. Location of balloon dilator before inflation for treatment
of esophageal strictures under endoscopic guidance.
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gauge.s Correct placement of the collapsed balloon was
facilitated by endoscopic guidance (Fig 3). The balloon
was positioned so that half of the balloon was passed
distal to the stricture and the remaining half of the bal-
loon was positioned proximal to the stricture (Fig 4).
During each dilatation attempt, the balloon pressure
was maintained for 90 seconds and the mucosa was clo-
sely observed for small tears and hemorrhage after
deflation of the balloon (Fig 5). The goal of each dilata-
tion attempt was to sequentially dilate the stricture in
1–2 mm increments without causing excessive tearing or
bleeding. Triamcinolone or methylprednisolone were
injected transendoscopically using a Wang transbronchi-
al aspiration needlet into the submucosa using a 4-
quadrant approach, located at positions 12, 3, 6, and 9
on a clock face (1.5 mg/quadrant, total 6 mg), at the
fourth dilatation attempt (Fig 6). Confirmation of depo-
sition of corticosteroids within the submucosa was by
visualization of a bleb within the esophageal wall. Cor-
ticosteroids were used in 4 cases and 3 of the animals
survived. Euthanasia in the nonsurvivor was associated
with dehiscence and secondary infection after esopha-
gostomy to relieve the obstruction before balloon dila-
tation. Corticosteroids used included intralesional
triamcinolone acetonideu 10 mg/mL (total dose: 6 mg
or 18 mg [n = 2]) or methylprednisolone acetatev
40 mg/mL (total dose: 40 or 200 mg [n = 2]), and sys-
temic dexamethasone SPw (4 mg/mL) 0.1 mg/kg IV q
24 h (n = 1). One horse received both intralesional
methylprednisolone acetate and systemic dexamethasone
SP. Intralesional triamcinolone acetonide was given
once in 1 horse and 3 times in the other, whereas meth-
ylprednisolone was given once in both horses. In all
instances some mucosal damage with a small amount of
hemorrhage was noted.
Balloon dilatation was performed in all horses and
the total number of dilatation procedures ranged from
1 to 6 (mean 3, median 2). During each procedure up
to 4 dilations of the balloon were performed dependent
on when mucosal damage was seen. The interval
between repeated dilatation procedures ranged from 1
to 18 days (mean 5.5 days, median: 4 days). General
inhalation anesthesia was undertaken in 2 of the cases
because of the temperament of the horses and the
remainder were performed under standing sedation.
Owners of all horses that survived were recommended
to initially feed their horse a diet of moist to soupy pel-
lets and dependent on progress move to dry pellets or
short fiber grass hay.
Complications
Eight horses had signs of aspiration pneumonia based
on auscultation (n = 8), thoracic radiographs (n = 5),
Fig 4. Location of balloon dilator during treatment for esopha-
geal stricture under endoscopic guidance.
Fig 5. Postballoon dilatation of an esophageal stricture showing
mucosal hemorrhage and erythema.
Fig 6. Insertion of a Wang needle into the esophageal submucosa
under endoscopic guidance for the administration of corticoster-
oids after dilatation of an esophageal stricture.
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and ultrasound (n = 2). Esophagostomy was performed
to remove an intramural cyst (n = 1; survivor) or for
unresolved esophageal obstruction (n = 1; nonsurvivor).
Esophageal ulceration was seen in 8 horses (Fig 7) and
gastric ulceration was noted in 1 horse.
Survival
Four horses, all less than 1 year of age, were eutha-
nized because of concurrent disorders including mega-
esophagus (n = 2), aspiration pneumonia (n = 1), or
complications after esophagostomy because of unresolv-
able esophageal obstruction.
Long-term follow up
Owners of 4 of the 5 surviving horses (1 lost to fol-
low up) were contacted. Three horses had returned to a
diet of grass hay or alfalfa with supplemental pellets
and 1 horse was solely on pellets. At the time of writ-
ing, the 4 horses were alive for 2, 5, 6, and 11 years
from presentation and were being used for various pur-
poses: at pasture (n = 2), breeding stallion (n = 1), or
breeding mare (n = 1).
Discussion
Balloon dilatation for the resolution of esophageal
strictures in horses can be successfully performed under
standing sedation or general anesthesia as demonstrated
in this study. Long-term (up to 11 years) follow-up
revealed that horses could return to a normal diet in
some cases. Intralesional corticosteroids were used in 3
cases that survived. All nonsurvivors were horses under
1 year of age and presented with, or developed, concur-
rent problems including megaesophagus, unresolved
esophageal obstruction requiring esophagostomy, or
severe aspiration pneumonia.
Four of the cases were pony breeds, whereas the rest
were horses of differing breeds. Although this case series
represents a relatively small study group, there was no
obvious breed predisposition. One horse was presented
with a severe wave mouth that could have led to the
esophageal obstruction as a result of lack of proper
mastication. No other predisposing factors were identi-
fied in this case series.
Balloon dilatation has been reported as an effective
method for treating esophageal strictures in horses in
previous publications, one of which was a report of 2
cases12 and 2 of which were individual case reports.11,13
None of the larger studies addressed the use of balloon
dilatation as a therapeutic modality for strictures.17–19
Assessment of the strictures in this case series was often
performed using endoscopy alone, as is frequently the
case in humans.9 Previous studies have stated the need
for contrast radiographic evaluation with or without
video fluoroscopy to assess stricture size12; however, this
procedure is not always needed and carries the addi-
tional risk of aspiration pneumonia.
The technique of balloon dilatation of esophageal
strictures is subjective in veterinary medicine, with
many variables not defined by controlled studies. These
include the sequence of dilatation, the optimal final
dilatation diameter, use of corticosteroids, postdilata-
tion drugs, postdilatation feeding regime, the elective
use of percutaneous endoscopic gastrostomy tubes in
small animals, and repeat elective dilatations (and at
what interval). We used the same dilatation protocol
as that used by our small animal internists and gastro-
enterologist (SLM) who have extensive experience in
balloon dilatation of esophageal strictures in dogs and
cats and as documented in the human literature.20 The
balloon dilators that we used facilitated expansion of
the esophageal stricture up to 3 mm depending upon
the filling pressure for each balloon dilator, and we
selected an initial balloon dilator diameter that was
25–50% larger than the estimated diameter of the stric-
ture for safety reasons (minimize likelihood of perfora-
tion) and because this allowed a gradual and
incremental increase in the diameter of the stricture.
Fig 7. Severe circumferential mucosal sloughing after resolution
of esophageal impaction.
Fig 8. Resolving esophageal stricture after balloon dilatation
2 days before re-examination.
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The sequence of subsequent larger dilations was then
determined by the degree of mucosal tearing at each
procedure and subsequent healing before the next pro-
cedure (Fig 8).
Intralesional steroid injections have been utilized in
humans and shown to significantly reduce the rate of
stricture recurrence with only 18% of steroid treated
humans requiring further treatment compared to 60%
of sham treated humans.15 In this study, triamcinolone
or methylprednisolone was injected into each quadrant
of the esophagus before, during, or after balloon dilata-
tion. The variable dose used was clinician based and
6 mg of triamcinolone has been proposed by the
authors as a safe amount for use in strictures based on
studies demonstrating the use of up to 80 mg intramus-
cularly as safe in horses.21 Intralesional corticosteroids
injections were repeated in 1 horse, although it was not
possible to determine whether the repeated administra-
tions affected the outcome of the horse in light of the
small number of horses injected. Although none of the
4 horses in this case series developed laminitis after cor-
ticosteroid administration; the risk of laminitis associ-
ated with these drugs must be discussed with the owner
before administration. However, the risk of laminitis
was reduced based on the low doses of steroids admin-
istered.
Antibiotic treatment in the case series varied among
clinicians and was often prescribed based on personal
preference. All antibiotic treatment was aimed at broad-
spectrum coverage to reduce the risk of a mixed growth
aspiration pneumonia. Seven horses received either pen-
icillin-based drugs or cephalosporin combined with an
aminoglycoside and 2 of the horses additionally
received metronidazole. Three horses were switched to
oral antibiotics to expedite discharge from the VMTH,
whereas 2 horses were switched to other antibiotics
(cephalosporin or a combination of penicillin and tri-
methoprim/sulfamethoxazole) because of a lack of reso-
lution of clinical signs.
Complications of esophageal obstruction and strictures
are well documented in horses. Aspiration pneumonia
can affect 72% of horses, whereas other complications
include esophageal mucosal ulceration, laryngeal hemi-
plegia, recurrent esophageal obstruction, laminitis sec-
ondary to steroid administration, megaesophagus, and
death.17,22 Previously described risk factors for complica-
tions associated with esophageal obstructions include
age, general anesthesia, pony breeds, and intact males.4,18
In a study of 109 equine cases with esophageal obstruc-
tion, 8 horses had strictures, 4 of which were foals with
an unknown etiology for their strictures.4 A survival rate
of 33% in horses with strictures has been documented
and those with chronic strictures were less likely to sur-
vive although that study did not address the use of bal-
loon dilatation.17 Those horses that received medical
treatment (antibiotics, corticosteroids, nonsteroidal anti-
inflammatories, and diet changes) had a poor survival
rate, due mostly to recurrent esophageal obstruction and
secondary aspiration pneumonia.17 Congenital strictures
are infrequently described in the equine literature and the
prevalence is unknown.11,23 In the current study only one
foal was noted to have a intramural cyst presumed to be
a congenital defect.
Limitations of this study included its retrospective
nature that precluded having identical examinations and
treatments performed in every case. In addition, the
small number of cases evaluated made statistical com-
parisons unfeasible.
As demonstrated in this study, endoscopic balloon
dilatation of esophageal strictures in horses frequently
has a successful outcome, and can be done safely
under standing sedation. Long-term follow up indicates
that a percentage of survivors can return to a normal
hay diet. The use of intralesional steroids is well docu-
mented in the human field and was utilized in 3 of the
4 cases highlighted with no recurrence of strictures
noted. The minimally invasive procedure offers an
alternative to surgery for esophageal strictures and can
have a good outcome in adult horses, ponies, and
foals. Case selection is important because concurrent
esophageal disease (megaesophagus, esophageal perfo-
ration, and aspiration pneumonia) adversely affects the
prognosis.
Footnotes
a Flunixin meglumine, Merck Animal Health, Intervet Inc, Sum-
mit, NJ
b Equi-Phar Phenylbutazone, Vedco Inc, St Joseph, MO
c Lidocaine hydrochloride 2%, VetOne, Boise, ID
d Buscopan, Boehringer Ingelheim, St Joseph, MO
e Torbugesic, Zoetis, Fort Dodge, IA
f Morphine, West-Ward, Eatontown, NJ
g Gentamicin sulfate, VetOne, Boise, ID
h Amikacin, TEVA, Sellersville, PA
i PenOne Pro, VetOne, Boise, ID
j Ampicillin, Auromedics, Dayton, NJ
k Naxcel, Zoetis, Kalamazoo, MI
l Metronidazole, TEVA, Sellersville, PA
m Trimethoprim and sulfamethoxazole, Amneal Pharmaceuticals,
Hauppauge, NY
n Doxycycline Hyclate, TEVA, Sellersville, PA
o Gastrogard, Merial Limited, Duluth, GA
p Sucralfate, Actavis Inc, Parsippany, NJ
q Ranitidine, Amneal Pharmaceuticals, Hauppauge, NY
r CRE wire-guided balloon dilator, Boston Scientific, Marlbor-
ough, MA
s Alliance II 60 mL Syringe/Gauge Assembly, Boston Scientific,
Marlborough, MA
t Wang Transbronchial Aspiration Needle, ConMed, Utica, NY
u Kenalog-10, Bristol-Myers Squibb, Princeton, NJ
v Methylprednisolone, Pfizer, New York, NY
w Dexamethasone-SP, VetOne, Meridian, ID
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